| Dr Junaid Ahmed, MD | |
|
12662 Telecom Dr, Temple Terrace, FL 33637-0935 | |
| (813) 910-8708 | |
| (855) 852-7153 |
| Full Name | Dr Junaid Ahmed |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 31 Years |
| Location | 12662 Telecom Dr, Temple Terrace, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639171630 | NPI | - | NPPES |
| 273676400 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | ME0093168 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kennedy Boulevard Dialysis | Tampa, FL | Dialysis facility |
| Usf Dialysis Center | Tampa, FL | Dialysis facility |
| Tampa General Hospital | Tampa, FL | Hospital |
| St Josephs Hospital | Tampa, FL | Hospital |
| Sarasota Memorial Hospital | Sarasota, FL | Hospital |
| Cape Coral Hospital | Cape coral, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Kidney Physicians Llc | 4385925650 | 140 |
News Archive
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,799,530 relating to methods of determining heart attack risk by detecting the KIF6 gene variant and reduction of such increased risk by statin therapy.
A new, streamlined approach to genetic engineering drastically reduces the time and effort needed to insert new genes into bacteria, the workhorses of biotechnology, scientists are reporting.
The World Bank released a report Monday, projecting "a 2.9 percent contraction in global GDP this year, as rich countries contract by 4.5 percent," the Wall Street Journal reports.
While the development of therapies designed to block "checkpoints" within the immune system has been one of the most exciting and noteworthy advances in cancer research in recent years, it's also been one of the most puzzling, leaving researchers to ask: Why don't these new therapies work for more patients, and why is their efficacy in controlling cancerous tumors often short-lived? A research team from Roswell Park Cancer Institute has shown that at least one answer -; and an excellent opportunity for unleashing the full potential of these promising immunotherapies -; may lie in the body's "fight or flight" reaction to stressors and in drugs already widely used to control and temporarily disable this stress response.
A new study has revealed the underlying mechanism of development of antibiotic resistance among Pseudomonas aeruginosa (P. aeruginosa). Pseudomonas is known to cause severe and often life threatening infections in humans. These infections become further difficult to treat because of the development of resistance against commonly used antibiotics.
› Verified 6 days ago
| Entity Name | Florida Kidney Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760831564 PECOS PAC ID: 4385925650 Enrollment ID: O20161228000460 |
News Archive
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,799,530 relating to methods of determining heart attack risk by detecting the KIF6 gene variant and reduction of such increased risk by statin therapy.
A new, streamlined approach to genetic engineering drastically reduces the time and effort needed to insert new genes into bacteria, the workhorses of biotechnology, scientists are reporting.
The World Bank released a report Monday, projecting "a 2.9 percent contraction in global GDP this year, as rich countries contract by 4.5 percent," the Wall Street Journal reports.
While the development of therapies designed to block "checkpoints" within the immune system has been one of the most exciting and noteworthy advances in cancer research in recent years, it's also been one of the most puzzling, leaving researchers to ask: Why don't these new therapies work for more patients, and why is their efficacy in controlling cancerous tumors often short-lived? A research team from Roswell Park Cancer Institute has shown that at least one answer -; and an excellent opportunity for unleashing the full potential of these promising immunotherapies -; may lie in the body's "fight or flight" reaction to stressors and in drugs already widely used to control and temporarily disable this stress response.
A new study has revealed the underlying mechanism of development of antibiotic resistance among Pseudomonas aeruginosa (P. aeruginosa). Pseudomonas is known to cause severe and often life threatening infections in humans. These infections become further difficult to treat because of the development of resistance against commonly used antibiotics.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Junaid Ahmed, MD 409 Bayshore Blvd., Tampa, FL 33606-2707 Ph: (813) 910-8708 | Dr Junaid Ahmed, MD 12662 Telecom Dr, Temple Terrace, FL 33637-0935 Ph: (813) 910-8708 |
News Archive
Celera Corporation today announced that the United States Patent and Trademark Office has issued United States Patent 7,799,530 relating to methods of determining heart attack risk by detecting the KIF6 gene variant and reduction of such increased risk by statin therapy.
A new, streamlined approach to genetic engineering drastically reduces the time and effort needed to insert new genes into bacteria, the workhorses of biotechnology, scientists are reporting.
The World Bank released a report Monday, projecting "a 2.9 percent contraction in global GDP this year, as rich countries contract by 4.5 percent," the Wall Street Journal reports.
While the development of therapies designed to block "checkpoints" within the immune system has been one of the most exciting and noteworthy advances in cancer research in recent years, it's also been one of the most puzzling, leaving researchers to ask: Why don't these new therapies work for more patients, and why is their efficacy in controlling cancerous tumors often short-lived? A research team from Roswell Park Cancer Institute has shown that at least one answer -; and an excellent opportunity for unleashing the full potential of these promising immunotherapies -; may lie in the body's "fight or flight" reaction to stressors and in drugs already widely used to control and temporarily disable this stress response.
A new study has revealed the underlying mechanism of development of antibiotic resistance among Pseudomonas aeruginosa (P. aeruginosa). Pseudomonas is known to cause severe and often life threatening infections in humans. These infections become further difficult to treat because of the development of resistance against commonly used antibiotics.
› Verified 6 days ago
Dr. Ronniel Mercado, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 13067 N Telecom Pkwy, Temple Terrace, FL 33637 Phone: 813-779-6303 Fax: 888-977-1998 | |
Dr. Charles E Sanders Jr., M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 12662 Telecom Dr, Temple Terrace, FL 33637 Phone: 813-910-8708 Fax: 855-852-7153 | |
Dr. Azzat A Ali, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 13067 N Telecom Pkwy, Temple Terrace, FL 33637 Phone: 313-718-1233 Fax: 888-806-8661 | |
Lalit K Kanaparthi, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 13067 N Telecom Pkwy, Temple Terrace, FL 33637 Phone: 813-779-6303 Fax: 888-977-1998 | |
Mukesh B Satodiya, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 13067 N Telecom Pkwy, Temple Terrace, FL 33637 Phone: 813-779-6303 | |
Emill Levasseur Sanchez, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 13067 N Telecom Pkwy, Temple Terrace, FL 33637 Phone: 813-779-6303 Fax: 888-977-1998 | |
Ronald S Schonwetter, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 12470 Telecom Dr Ste 300w, Temple Terrace, FL 33637 Phone: 813-871-8111 |